With the growing attention the cannabis industry is receiving these days, now is the best time to think about investing in this sector.
With its legalization in many states, the cannabis industry is experiencing a boost in medical marijuana, with cannabidiol oil showing the most promise.
Aurora Cannabis acquires license to cannabis pre-roll technology for CA$7 million. The said machines can produce cannabis rolls and cones in massive rates.
A study revealed that apart from its health benefits, the cannabis industry can provide more opportunities for employment and generate more tax revenue.
GW Pharmaceuticals’ Epidiolex is the first FDA-approved cannabis-based drug.
After the Senate's approval, the Canadian government did not accept some of the amendments in the Cannabis Act.
With the legalization of cannabis in some U.S. states, the cannabis industry is projected to grow as much as $21 billion by 2020.
A recent study revealed that a significant drop in binge drinking ratings were observed among states which permit the use of recreational cannabis.
The integration of CBD in cosmetics has resulted in the cannabidiol and beauty-product markets flourishing.
With stiff competition from established medical companies and the stigma linked to marijuana, the challenges are real.